Intrinsic Edge Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Intrinsic Edge Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100,000	Closed	-$714K	–	178
2024 Q2	$714K	Buy	+100,000	New	+$765K	0.06%	135
2021 Q4	–	Sell	-200,866	Closed	-$4.33M	–	287
2021 Q3	$4.33M	Hold	200,866	–	–	0.3%	125
2021 Q2	$5.15M	Sell	200,866 -20,000	-9%	-$427K	0.3%	128
2021 Q1	$4.03M	Sell	220,866 -165,100	-43%	-$2.74M	0.27%	132
2020 Q4	$4.45M	Buy	+385,966	New	+$3.53M	0.33%	100

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Intrinsic Edge Capital Management's CDMO Position: Q3 2024 in Review

Intrinsic Edge Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2024, closing a stake of 100,000 shares — an estimated $714K sold.

Intrinsic Edge Capital Management first reported a position in CDMO in Q4 2020 and held it in 5 quarters. The position peaked at $5.15M in Q2 2021. 172 funds tracked by Wall St. Rank hold CDMO as of Q3 2024.

Intrinsic Edge Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Intrinsic Edge Capital Management sold 100,000 Avid Bioservices, Inc. Common Stock shares in Q3 2024, an estimated $714K.
Intrinsic Edge Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Intrinsic Edge Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $5.15M in Q2 2021.
172 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2024.

Based on Intrinsic Edge Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.